Menopause Hormone Therapy
Menopause treatment research | Indications • Formulations • Safety Context
Common names: menopausal hormone therapy · MHT · HRT · hormone replacement therapy · menopause hormone therapy
- Evidence searched through
- August 28, 2026
- Last reviewed
- August 28, 2026
- Current version
- 1.0
4V Take
What the research shows.
Menopause hormone therapy is not one uniform exposure. Researchers study different estrogen-containing therapies, with or without a progestogen, in different populations and for different outcomes. The evidence is meaningful, but route, formulation, timing, and indication change the question being asked.
Explore the evidenceResearch Interest
Why are people interested?
Researchers are studying Menopause Hormone Therapy across Vasomotor Symptoms • Bone • Safety Context. These are areas of research interest, not guaranteed outcomes.
Evidence Context
What have researchers looked at?
This approved record brings together the research settings represented in its selected public sources. Evidence settings answer different questions, so human, animal, laboratory, and research-review findings stay distinct.
Current research context
Research stage describes the maturity of the current topic record. Source context describes the evidence settings represented in the selected public sources below; they are not interchangeable.
- Research stage
- Established, context-dependent
- Selected source context
- Human
At a Glance
Research snapshot.
- 01Human Research
Large trials, guidelines, and labeling - 02Research Stage
Established, context-dependent - 03Most Studied Areas
Vasomotor Symptoms • Bone • Safety Context - 04Key Distinction
Route • Formulation • Timing • Uterus Status - 05Regulatory Context
FDA-approved prescription therapies
Research Pathway
Follow the questions.
Choose a pathway to read its approved 4V Take. Each view stays focused on one question at a time.
4V Take
Researchers study prescription estrogen-containing therapies, with or without a progestogen, for defined menopause-related questions. The evidence is not one interchangeable story because route, formulation, timing, indication, and participant characteristics differ.
- Evidence bucket
- guideline
- Research stage
- established
- Route / format
- systemic and local prescription therapies; estrogen-alone and estrogen-plus-progestogen contexts
Explore the evidence
large human randomized controlled trial
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
large human randomized controlled trial
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
professional position statement
The 2022 hormone therapy position statement of The North American Menopause Society.
4V Take
The Women's Health Initiative randomized trials evaluated different hormone regimens in different participant groups. Their findings provide important safety and outcome context, but they are not interchangeable across estrogen-alone, estrogen-plus-progestin, or other products.
- Evidence bucket
- human clinical
- Research stage
- established
- Route / format
- specific oral Women's Health Initiative regimens
Explore the evidence
large human randomized controlled trial
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
large human randomized controlled trial
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
FDA regulatory and labeling context
Menopausal Hormone Therapies with Updated Prescribing Information.
4V Take
Route and formulation change the exposure being studied. Professional guidance and regulatory materials treat estrogen-alone, estrogen-plus-progestogen, systemic, and local products as distinct contexts rather than evidence that can be collapsed into one answer.
- Evidence bucket
- guideline
- Research stage
- established
- Route / format
- oral, transdermal, local, estrogen-alone, and estrogen-plus-progestogen contexts
Explore the evidence
large human randomized controlled trial
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
large human randomized controlled trial
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
professional position statement
The 2022 hormone therapy position statement of The North American Menopause Society.
4V Take
FDA prescribing information and professional guidance describe material benefit-risk and contraindication context for approved products. That context is product- and patient-specific, so it should not be reduced to blanket reassurance or alarm.
- Evidence bucket
- regulatory context
- Research stage
- established
- Route / format
- FDA-approved prescription product labeling
Explore the evidence
FDA regulatory and labeling context
Menopausal Hormone Therapies with Updated Prescribing Information.
professional-society patient education context
Hormone Therapy for Menopause.
large human randomized controlled trial
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
4V Take
Evidence should remain tied to the studied population, indication, timing, formulation, route, and outcome. A favorable or unfavorable result for one question does not settle every other menopause hormone therapy question.
- Evidence bucket
- mixed
- Research stage
- established
- Route / format
- population- and product-specific evidence context
Explore the evidence
large human randomized controlled trial
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
large human randomized controlled trial
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
professional position statement
The 2022 hormone therapy position statement of The North American Menopause Society.
Selected Sources
Explore the evidence.
Open an approved public source to inspect its study context, limitations, and original record where available.
large human randomized controlled trial
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
2002 · PMID: 12117397 · peer reviewed
large human randomized controlled trial
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
2004 · PMID: 15082697 · peer reviewed
professional position statement
The 2022 hormone therapy position statement of The North American Menopause Society.
2022 · PMID: 35797481 · peer reviewed
FDA regulatory and labeling context
Menopausal Hormone Therapies with Updated Prescribing Information.
2026 · URL: https://www.fda.gov/drugs/drug-safety-and-availability/menopausal-hormone-therapies-updated-prescribing-information · government source
professional-society patient education context
Hormone Therapy for Menopause.
2026 · URL: https://www.acog.org/womens-health/faqs/hormone-therapy-for-menopause · professional society
Research Status
Living research, deliberately tracked.
- Evidence searched globally through:
- August 28, 2026
- Last reviewed
- August 28, 2026
- Version
- 1.0
What Changed
Current record.
No later approved public release is available beyond the current topic record.
Evidence Boundaries
What are researchers still working out?
Study settings, measures, and limitations matter. A mechanism does not establish an outcome, animal or laboratory findings do not establish a human benefit, and a small study does not create consensus. Open each selected source for the approved record behind its finding.
Regulatory Context
Context, not a shortcut.
This topic’s selected public record includes regulatory or other context sources. They can help explain the setting in which research is discussed, but regulatory status does not by itself prove or disprove scientific value. Open the original source for its exact context.
Save / Follow
Keep this research close.
Save and Follow remain private account preferences. Following does not activate monitoring or notifications.
Loading member research actions.